Foley导尿管联合缩宫素与单用缩宫素用于胎膜早破后引产的随机对照试验
这项随机多中心试验纳入201例孕34周及以上、胎膜早破且宫颈条件不佳的孕妇,比较经宫颈Foley导尿管联合缩宫素与单用缩宫素引产。两组引产至分娩时间无显著差异(13.9小时 vs 14.4小时,P=.69),但Foley组临床绒毛膜羊膜炎发生率更高(8% vs 0%,P<.01)。
要点
- Foley联合缩宫素未缩短胎膜早破孕妇的引产至分娩时间。
- Foley组临床绒毛膜羊膜炎发生率为8%,单用缩宫素组为0%(P<.01)。
- 两组其他感染性并发症及研究变量均无差异。
核心结论
- 在胎膜早破患者中,经宫颈Foley导尿管联合缩宫素与单用缩宫素相比不缩短分娩时间,但可能增加羊膜腔内感染发生率。
研究设计与样本
- 随机多中心试验,纳入孕34周及以上、单胎活产、胎膜早破、宫颈检查不佳(扩张≤2 cm且消退≤80%)且无引产禁忌的孕妇201例,Foley组93例、缩宫素组108例,按意向治疗分析。
主要发现
- 引产至分娩时间Foley组为13.9小时(±6.9 SD),缩宫素组为14.4小时(±7.9 SD),两组无显著差异(P=.69)。
- 临床绒毛膜羊膜炎Foley组为8%,缩宫素组为0%,Foley组高于缩宫素组(P<.01)。
- 其他感染性并发症及所有其他研究变量两组均无差异。
关键数值与推荐
- 主要结局为引产至分娩时间,预设检测2.5小时差异,需194例结局数据,把握度80%、双侧α=5%。
- Foley导尿管经宫颈注入30 cc,同时联合缩宫素输注;缩宫素给药各中心标准化。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To evaluate the use of a transcervical Foley catheter plus oxytocin infusion compared with oxytocin infusion alone for labor induction and cervical ripening in women 34 weeks of gestation or greater with prelabor rupture of membranes. METHODS: This is a randomized, multicenter trial of women with a live, singleton gestation at 34 weeks of gestation or greater with prelabor rupture of membranes, an unfavorable cervical examination (less than or equal to 2 cm dilated and less than or equal to 80% effaced), and no contraindication to labor. Participants were randomly allocated to a transcervical Foley catheter inflated to 30 cc with concurrent oxytocin infusion or oxytocin infusion alone. Oxytocin administration was standardized across sites. The primary study outcome was interval from induction to delivery. To detect a 2.5-hour difference in the interval from induction to delivery, we required outcome data on 194 women, assuming 80% power and a two-tailed α of 5%. Analysis was by intent to treat. RESULTS: We enrolled 201 women: 93 were allocated to Foley and 108 to oxytocin. Demographics were similar between the groups. Time to delivery was not significantly different between groups: in the Foley group, it was 13.9 hours (±6.9 SD) compared with 14.4 hours (±7.9 SD) in the oxytocin group (P=.69). There were more cases of clinical chorioamnionitis (8% compared with 0%, P<.01) in the Foley group compared with the oxytocin group. There were no differences for other infectious morbidities or any other variable studied. CONCLUSION: In patients with prelabor rupture of membranes, the use of a transcervical Foley catheter in addition to oxytocin does not shorten the time to delivery compared with oxytocin alone, but may increase the incidence of intraamniotic infection. CLINICAL TRIAL REGISTRATION: ClinicalTrials.gov, NCT01973036.
引用
- Mackeen AD, Durie DE, Lin M, et al. Foley Plus Oxytocin Compared With Oxytocin for Induction After Membrane Rupture: A Randomized Controlled Trial. Obstet Gynecol. 2018. PMID: 29215519. doi:10.1097/AOG.0000000000002374
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。